Current practices of Asia-Pacific cardiologists in the utilization of bioresorbable scaffolds.

Autor: Chanana BB; Maharaja Agrasen Hospital, New Delhi, India., Chandra P; Medanta Medicity, Haryana, India., Cheng JJ; Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan., Dick R; Epworth Hospital, Melbourne, Victoria, Australia., Gwon HC; Samsung Medical Center, Seoul, Republic of Korea., Hiremath MS; Ruby Hall Clinic, Pune, Maharashtra, India., Huan DQ; Heart Institute HCM, Ho Chi Minh City, Vietnam., Jeamanukoolkit A; Police General Hospital, Bangkok, Thailand., Jiang T; The Second Hospital of Tianjin Medical University, Tianjin, China., Kwok OH; Hong Kong Sanatorium & Hospital, Hongkong, China., Lim MCL; Mount Elizabeth Novena Hospital, Singapore, Singapore., Low AF; National University Hospital, Singapore, Singapore., Mathew R; Lisie Hospital, Ernakulam, Kerala, India., Mathew SK; Lilavati Hospital, Mumbai, India., McClean D; Christchurch Hospital, Christchurch, New Zealand., Nakamura S; New Tokyo Hospital, Chiba, Japan., Nguyen M; Fiona Stanley Hospital, Murdoch, Australia., Qiao S; Fuwai Cardiovascular Hospital, Beijing, China., Santoso T; Medistra Hospital, Jakarta, Indonesia., Saxena S; Max Hospital, New Delhi, India., Schultz C; Royal Perth Hospital Campus, University of Western Australia, Australia., Sengottuvelu G; Apollo Hospital, Chennai, India., Seth A; Fortis Escorts Heart Institute, India., Simonton CA; Abbott Vascular, Santa Clara, USA., Soo CS; HSC Medical Centre, Kuala Lumpur, Malaysia., Sudhir K; Abbott Vascular, Santa Clara, USA. Electronic address: krishna.sudhir@av.abbott.com., Tsai CT; Mackay Memorial Hospital, Taipei, Taiwan., Wasan U; King Chulalongkorn Memorial Hospital, Bangkok, Thailand., Whelan A; Fiona Stanley Hospital, Murdoch, Australia., Wong C; Hong Kong Sanatorium & Hospital, Hongkong, China., Yap YG; Prince Court Medical Centre, Kuala Lumpur, Malaysia.
Jazyk: angličtina
Zdroj: International journal of cardiology [Int J Cardiol] 2016 Nov 01; Vol. 222, pp. 832-840. Date of Electronic Publication: 2016 Aug 01.
DOI: 10.1016/j.ijcard.2016.07.273
Abstrakt: Background & Aims: Although Absorb Bioresorbable Vascular Scaffolds (A-BVS) are routinely used in the Asia-Pacific, there is little information on patient selection or deployment technique here. This document investigates the experiences of leading interventional cardiologists from the Asia-Pacific region with a focus on patient characteristics, deployment techniques and management.
Methods and Results: A detailed questionnaire was distributed to 28 highly-experienced interventional cardiologists ('Authors') from 13 Asia-Pacific countries. The results were discussed at a meeting on patient selection, technical consideration, deployment practices and patient management. Potential patient benefits of Absorb compared to metallic DES, the learning curve for patient selection and preparation, device deployment, and subsequent patient management approaches are presented.
Conclusions: Current practices are derived from guidelines optimized for European patients. Differences in approach exist in the Asia-Pacific context, including limited access to imaging and frequency of occurrence of complex lesions. Nevertheless, the use of the Absorb BVS ('Absorb') in certain Asia-Pacific countries has flourished and practices here are continuing to mature.
(Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: